WELL Health Technologies Corp header image

WELL Health Technologies Corp

WELL

Equity

ISIN null / Valor 42769021

Toronto Stock Exchange (2026-06-09)
CAD 4.76-1.65%

WELL Health Technologies Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

WELL Health Technologies Corp is a prominent healthcare company in Canada, recognized as the largest owner and operator of clinics offering a comprehensive range of services including primary, allied, diagnostic, specialized, and preventative care. In the United States, WELL extends its reach as a national telehealth provider, operator of physical clinics, and provider of anesthesia services across 18 states. The company leverages a dual approach to healthcare delivery through its extensive network of physical clinics and a robust suite of virtual services. These virtual services encompass telehealth, electronic medical records (EMR), billing, revenue cycle management, ePharma, digital booking, e-Referral, and e-prescription services. WELL's Practitioner Enablement Platform offers over 34,000 healthcare providers access to digital tools designed to enhance clinic efficiency and patient health outcomes. This platform supports both practitioners within the WELL Health Clinic Network and those operating independently, providing flexible, scalable solutions to meet diverse healthcare needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

17.2%1Y
-7.39%3Y
-39.7%5Y

Performance

40.8%1Y
43.5%3Y
45.5%5Y

Volatility

Market cap

872 M

Market cap (USD)

Daily traded volume (Shares)

1,163,823

Daily traded volume (Shares)

1 day high/low

7.045 / 6.86

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 34.06
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.77%USD 26.97
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%USD 3.11
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 67.68
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.28%USD 34.10
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.93%INR 1,575.35
PTC Therapeutics Inc
PTC Therapeutics Inc PTC Therapeutics Inc Valor: 2515234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.97%USD 73.68
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.05%USD 104.19
AnaptysBio, Inc.
AnaptysBio, Inc. AnaptysBio, Inc. Valor: 29675116
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%USD 51.63
CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%USD 56.67